Press Releases

Search Press Releases

Looking for something specific?

For further information, please contact:

Jeffrey Stevens
Chief Executive Officer
Psyched Wellness Ltd.
t: (647) 400-8494
e: jstevens@psyched-wellness.com
Website: http://www.psyched-wellness.com

Investor Contacts:
Tim Regan/Sophia Bashford
KCSA Strategic Communications
t: (978) 505-2478
e: PsychedWellness@kcsa.com

Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

January 21, 2021

Read more

Psyched Wellness Announces New OTCQB Ticker: PSYCF

January 19, 2021

Read more

Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol

January 14, 2021

Read more

Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol

January 6, 2021

Read more

Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

December 28, 2020

Read more

Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria

December 23, 2020

Read more

Psyched Wellness Successfully Completes Extraction of a Legal Psychedelic Mushroom

December 15, 2020

Read more

Psyched Wellness Successfully Completes Writing the Final Extraction Protocol, the Assembly of Safety & Efficacy Narratives, and Writing the Safety Data Sheet (SDS) For Its First Product

December 10, 2020

Read more

Psyched Wellness Advisor Kevin Feeney Releases Book on Amanita Muscaria

December 9, 2020

Read more

Psyched Wellness LTD. Adds Aaron Slater to the Advisory Board

December 8, 2020

Read more
← 1 … 8 9 10 11 12 →